Bold Brain Ventures

Bold Brain Capital is a venture capital firm that builds a specialized portfolio of early-stage life sciences companies. It focuses on identifying and investing in ventures leveraging AI-enabled technologies for healthcare. Their core capability involves deploying capital and offering strategic guidance to emerging companies developing disruptive medical AI solutions.

Founded in 2018, Bold Brain Capital was established by general partners Michael Thomas, Will Anlyan, and Tomislav Deur. Their founding insight recognized the critical need for physician involvement in advancing medical AI. Drawing on extensive experience in clinical practice, venture capital, and life sciences, they created a platform to enable active medical community participation in AI-driven healthcare innovation.

Bold Brain Capital serves early-stage healthcare AI startups, offering investment and access to its proprietary network of physicians. The firm’s vision is to cultivate an ecosystem where medical professionals directly contribute to and influence AI's evolution in healthcare. This ensures developing technologies genuinely enhance patient care, optimize practices, and improve clinical outcomes.